Investment
Features
FeesSafety
Academy
More
Pluang+

Compare iShares MSCI Canada (TSX) (EWC) vs Twist Bioscience Corp (TWST) Price & Performance

iShares MSCI Canada (TSX)Trade
Twist Bioscience CorpTrade

Price performance (Past 24H)

Key statistics

iShares MSCI Canada (TSX) vs Twist Bioscience Corp — how do they compare? iShares MSCI Canada (TSX) trades at $61.53, while Twist Bioscience Corp trades at $123.12 (market cap $7.82B). Which is the better fit depends on your goals.

EWCTWST
Sector
Broad Market / FactorHealth
52-Week High
$61.51$124.88
52-Week Low
$47.00$24.16
Market Cap
$7.82B
Enterprise Value
$7.75B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

iShares MSCI Canada (TSX)

EWC, the iShares MSCI Canada ETF, trades at $61.30, up 0.99% on the day, with a bullish technical signal from moving averages but overbought RSI readings. The fund faces headwinds from renewed U.S.-Canada trade tensions, including 50% tariffs announced in July 2026, though bullish analyst views highlight resilience due to energy and potash exclusions. Key financial ratios are unavailable in the provided data.

Outlook is mixed: technical strength supports near-term gains, but trade policy risks and overbought conditions warrant caution. Investment appeal hinges on Canada's resource-heavy economy navigating tariffs, with diversification benefits for U.S. investors. Risks include escalated trade war impacts on Canadian exports and market volatility.

Twist Bioscience Corp

Twist Bioscience (TWST) trades at $115.67, up 6.04% in the last session, with bullish technical signals from moving averages and a recent analyst upgrade. Revenue growth is strong, with fiscal 2026 Q3 revenue up 23% year-over-year to $118.4 million, though the company remains unprofitable with negative net income margins. A recent $300 million public offering at $96 per share indicates capital raising for expansion.

The outlook is mixed: robust revenue growth and high analyst buy ratings (78.57%) support upside potential, but persistent losses, cash burn, and high valuation ratios pose significant risks. Investors should weigh growth prospects against financial sustainability concerns.

Returns comparison

Trailing returns across standard periods

About iShares MSCI Canada (TSX)

EWC is a country-specific ETF that tracks the performance of the Canadian equity market. It provides exposure to large and mid-sized companies in Canada, with heavy concentrations in financials and energy, including Royal Bank of Canada, Shopify, and Enbridge.

Read more on EWC

About Twist Bioscience Corp

Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.

Read more on TWST